Mingtiandi
Username
Grosvenor currently has four projects in Tokyo including Grosvenor Place Kamizono-cho in Yoyogi Park
Privately-held Grosvenor on Monday announced the appointment of Kozo Hiratani as president of the UK property group’s business in Japan, effective 1 February.
Hiratani has extensive experience in the real estate industry, having worked at Mitsui Fudosan for 25 years before joining Grosvenor, a centuries-old firm owned by the Duke of Westminster and his family.
Hiratani will also sit on the board of Grosvenor Asia Pacific and serve as an executive committee member.
“Following a thorough search process, I am very pleased to announce the appointment of Kozo Hiratani as president of our Japan business,” Benjamin Cha, chief executive of Grosvenor Asia Pacific, said in a release. “Hiratani-san is an experienced executive who brings a wealth of highly relevant leadership, strategy, investment, project delivery and asset management experience to the team and
ResearchAndMarkets.com’s offering.
From the early 1900s through the mid-2000s, the global cord blood banking industry proliferated with cord blood banks emerging in all major healthcare markets worldwide. From 2005 to 2010, the market reached saturation and stabilized. From 2010 to 2020, the market began to aggressively consolidate, creating both threats and opportunities within the industry.
Serious threats to the industry include low rates of utilization for stored cord blood, expensive cord blood transplantation procedures, difficulty educating obstetricians about cellular therapies, and an increasing trend toward industry consolidation. Opportunities for the industry include price efficiencies associated with scale and consolidation, accelerated regulatory pathways for cord blood and tissue-based cell therapies, and progress with
Share this article
Share this article
ResearchAndMarkets.com s offering.
From the early 1900s through the mid-2000s, the global cord blood banking industry proliferated with cord blood banks emerging in all major healthcare markets worldwide. From 2005 to 2010, the market reached saturation and stabilized. From 2010 to 2020, the market began to aggressively consolidate, creating both threats and opportunities within the industry.
Serious threats to the industry include low rates of utilization for stored cord blood, expensive cord blood transplantation procedures, difficulty educating obstetricians about cellular therapies, and an increasing trend toward industry consolidation. Opportunities for the industry include price efficiencies associated with scale and consolidation, accelerated regulatory pathways for cord blood and tissue-based cell therapies, and progress with
Global Prostate Cancer Therapeutics Market Size study, by Type, Application and Regional Forecasts 2020-2027 einnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from einnews.com Daily Mail and Mail on Sunday newspapers.